$ERAS
Erasca, Inc.

2022 Q4 Form 10-Q Financial Statement

#000095017022023926 Filed on November 09, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3 2021 Q3
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $8.722M $8.778M $6.916M
YoY Change 26.04% 26.92% 242.38%
% of Gross Profit
Research & Development $29.36M $28.18M $19.95M
YoY Change 21.67% 41.27% 120.02%
% of Gross Profit
Depreciation & Amortization $933.0K $771.0K $191.0K
YoY Change 191.56% 303.66% 37.41%
% of Gross Profit
Operating Expenses $38.08M $36.96M $46.04M
YoY Change 22.64% -19.72% 312.47%
Operating Profit -$36.96M -$46.04M
YoY Change -19.72% 312.47%
Interest Expense $2.878M $1.522M $49.00K
YoY Change 3497.5% 3006.12% 28.95%
% of Operating Profit
Other Income/Expense, Net -$50.00K $1.473M -$25.00K
YoY Change -109.92% -5992.0% -104.5%
Pretax Income -$135.3M -$35.49M -$46.07M
YoY Change 343.97% -22.97% 334.29%
Income Tax
% Of Pretax Income
Net Earnings -$135.3M -$35.49M -$46.07M
YoY Change 343.97% -22.97% 334.29%
Net Earnings / Revenue
Basic Earnings Per Share -$0.29 -$0.46
Diluted Earnings Per Share -$1.06 -$0.29 -$464.7K
COMMON SHARES
Basic Shares Outstanding 122.4M 122.1M 121.2M
Diluted Shares Outstanding 120.8M 99.13M

Balance Sheet

Concept 2022 Q4 2022 Q3 2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $435.6M $355.9M $486.6M
YoY Change 5.1% -26.86%
Cash & Equivalents $284.2M $219.3M $445.8M
Short-Term Investments $151.4M $136.7M $40.83M
Other Short-Term Assets $8.876M $9.823M $5.668M
YoY Change 60.16% 73.31%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $444.5M $365.8M $492.3M
YoY Change 5.83% -25.71%
LONG-TERM ASSETS
Property, Plant & Equipment $24.82M $24.88M $8.520M
YoY Change 55.54% 191.96%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $0.00 $9.569M
YoY Change -100.0%
Other Assets $4.772M $4.775M $1.665M
YoY Change 63.99% 186.79%
Total Long-Term Assets $70.41M $80.68M $29.64M
YoY Change -13.5% 172.24%
TOTAL ASSETS
Total Short-Term Assets $444.5M $365.8M $492.3M
Total Long-Term Assets $70.41M $80.68M $29.64M
Total Assets $514.9M $446.4M $521.9M
YoY Change 2.69% -14.47%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $23.05M $4.319M $1.324M
YoY Change 392.82% 226.21%
Accrued Expenses $23.95M $21.43M $15.21M
YoY Change 27.26% 40.93%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $48.69M $27.68M $19.59M
YoY Change 84.56% 41.31%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $573.0K $53.43M $19.37M
YoY Change -96.9% 175.86%
Total Long-Term Liabilities $573.0K $53.43M $19.37M
YoY Change -96.9% 175.86%
TOTAL LIABILITIES
Total Short-Term Liabilities $48.69M $27.68M $19.59M
Total Long-Term Liabilities $573.0K $53.43M $19.37M
Total Liabilities $103.1M $81.11M $38.96M
YoY Change 129.59% 108.2%
SHAREHOLDERS EQUITY
Retained Earnings -$481.0M -$345.7M -$207.7M
YoY Change 101.96% 66.44%
Common Stock $893.9M $712.4M $690.7M
YoY Change 28.64% 3.15%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $411.9M $365.3M $483.0M
YoY Change
Total Liabilities & Shareholders Equity $514.9M $446.4M $521.9M
YoY Change 2.69% -14.47%

Cashflow Statement

Concept 2022 Q4 2022 Q3 2021 Q3
OPERATING ACTIVITIES
Net Income -$135.3M -$35.49M -$46.07M
YoY Change 343.97% -22.97% 334.29%
Depreciation, Depletion And Amortization $933.0K $771.0K $191.0K
YoY Change 191.56% 303.66% 37.41%
Cash From Operating Activities -$26.37M -$23.94M -$23.22M
YoY Change 17.3% 3.13% 66.08%
INVESTING ACTIVITIES
Capital Expenditures $864.0K -$1.792M -$4.674M
YoY Change -114.82% -61.66% 1184.07%
Acquisitions
YoY Change
Other Investing Activities -$4.003M -$53.44M -$265.0K
YoY Change -93.11% 20064.91% -99.7%
Cash From Investing Activities -$4.867M -$55.23M -$4.939M
YoY Change -92.39% 1018.22% -94.44%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 96.20M 427.0K 317.6M
YoY Change 8589.79% -99.87% 127.47%
NET CHANGE
Cash From Operating Activities -26.37M -23.94M -23.22M
Cash From Investing Activities -4.867M -55.23M -4.939M
Cash From Financing Activities 96.20M 427.0K 317.6M
Net Change In Cash 64.96M -78.75M 289.4M
YoY Change -176.13% -127.21% 684.88%
FREE CASH FLOW
Cash From Operating Activities -$26.37M -$23.94M -$23.22M
Capital Expenditures $864.0K -$1.792M -$4.674M
Free Cash Flow -$27.24M -$22.15M -$18.55M
YoY Change 63.56% 19.46% 36.19%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
CY2022Q3 us-gaap Preferred Stock Value
PreferredStockValue
dei Entity Central Index Key
EntityCentralIndexKey
0001761918
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
dei Amendment Flag
AmendmentFlag
false
CY2022Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-40602
dei Entity Registrant Name
EntityRegistrantName
ERASCA, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
83-1217027
dei Entity Address Address Line1
EntityAddressAddressLine1
3115 Merryfield Row
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 300
dei Entity Address City Or Town
EntityAddressCityOrTown
San Diego
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92121
dei City Area Code
CityAreaCode
858
dei Local Phone Number
LocalPhoneNumber
465-6511
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Security12b Title
Security12bTitle
Common Stock, $0.0001 par value per share
dei Trading Symbol
TradingSymbol
ERAS
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
122361616
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
219260000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
360487000
CY2022Q3 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
136668000
CY2021Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
53988000
CY2022Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
9823000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
5542000
CY2022Q3 us-gaap Assets Current
AssetsCurrent
365751000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
420017000
CY2022Q3 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
9569000
CY2021Q4 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
44770000
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
24875000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
15954000
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
41051000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
17356000
CY2022Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
408000
CY2021Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
408000
CY2022Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
4775000
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2910000
CY2022Q3 us-gaap Assets
Assets
446429000
CY2021Q4 us-gaap Assets
Assets
501415000
CY2022Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
4319000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
4677000
CY2022Q3 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
22332000
CY2021Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
21419000
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1028000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
285000
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
27679000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
26381000
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
53431000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
18506000
CY2022Q3 us-gaap Liabilities
Liabilities
81110000
CY2021Q4 us-gaap Liabilities
Liabilities
44887000
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
80000000
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
80000000
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
800000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
800000000
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
122306969
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
121382547
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
121024938
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
119102505
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
12000
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
12000
CY2022Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
712407000
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
694844000
CY2022Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1379000
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-162000
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-345721000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-238166000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
365319000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
456528000
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
446429000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
501415000
CY2022Q3 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
28184000
CY2021Q3 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
19951000
us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
83101000
us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
49794000
CY2021Q3 us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
1680000
us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
2000000
us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
10848000
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8778000
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6916000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
24271000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
15696000
CY2021Q3 eras Contribution Of Common Stock
ContributionOfCommonStock
17497000
eras Contribution Of Common Stock
ContributionOfCommonStock
17497000
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
36962000
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
46044000
us-gaap Operating Expenses
OperatingExpenses
109372000
us-gaap Operating Expenses
OperatingExpenses
93835000
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-36962000
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-46044000
us-gaap Operating Income Loss
OperatingIncomeLoss
-109372000
us-gaap Operating Income Loss
OperatingIncomeLoss
-93835000
CY2022Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
1522000
CY2021Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
49000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
2024000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
110000
CY2022Q3 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
49000
CY2021Q3 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
74000
us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
207000
CY2022Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
427000
us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
190000
eras Change In Fair Value Of Preferred Stock Purchase Right Liability
ChangeInFairValueOfPreferredStockPurchaseRightLiability
1615000
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1473000
CY2021Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-25000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1817000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1535000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-35489000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-46069000
us-gaap Net Income Loss
NetIncomeLoss
-107555000
us-gaap Net Income Loss
NetIncomeLoss
-92300000
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.29
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.29
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.46
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.46
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.90
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.90
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.90
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.90
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
120798322
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
120798322
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
99127286
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
99127286
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
120166023
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
120166023
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
48584029
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
48584029
CY2022Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-156000
CY2021Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
1000
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-1217000
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-2000
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-35645000
CY2021Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-46068000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-108772000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-92302000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
456528000
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
460000
CY2022Q1 eras Stock Issued During Period Value Vesting Of Early Exercised Stock Options
StockIssuedDuringPeriodValueVestingOfEarlyExercisedStockOptions
479000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4442000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-36458000
CY2022Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-789000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
424662000
CY2022Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
375000
CY2022Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
617000
CY2022Q2 eras Stock Issued During Period Value Vesting Of Early Exercised Stock Options
StockIssuedDuringPeriodValueVestingOfEarlyExercisedStockOptions
238000
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5055000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-35608000
CY2022Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-272000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
395067000
CY2022Q3 eras Stock Issued During Period Value Vesting Of Early Exercised Stock Options
StockIssuedDuringPeriodValueVestingOfEarlyExercisedStockOptions
238000
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5232000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-35489000
CY2022Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-156000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
365319000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-113984000
CY2021Q1 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
1680000
CY2021Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
94000
CY2021Q1 eras Stock Issued During Period Value Vesting Of Early Exercised Stock Options
StockIssuedDuringPeriodValueVestingOfEarlyExercisedStockOptions
174000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
795000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-18017000
CY2021Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-1000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-129259000
CY2021Q2 eras Stock Issued During Period In Connection With Licensing Agreement Value
StockIssuedDuringPeriodInConnectionWithLicensingAgreementValue
5488000
CY2021Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
180000
CY2021Q2 eras Stock Issued During Period Value Vesting Of Early Exercised Stock Options
StockIssuedDuringPeriodValueVestingOfEarlyExercisedStockOptions
174000
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1636000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-28214000
CY2021Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-2000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-149997000
CY2021Q3 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
340798000
CY2021Q3 eras Disgorgement Of Stockholders Short Swing Profits
DisgorgementOfStockholdersShortSwingProfits
553000
CY2021Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
21000
CY2021Q3 eras Stock Issued During Period Value Vesting Of Early Exercised Stock Options
StockIssuedDuringPeriodValueVestingOfEarlyExercisedStockOptions
171000
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3017000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-46069000
CY2021Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
1000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
482991000
us-gaap Profit Loss
ProfitLoss
-107555000
us-gaap Profit Loss
ProfitLoss
-92300000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1708000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
509000
us-gaap Share Based Compensation
ShareBasedCompensation
14729000
us-gaap Share Based Compensation
ShareBasedCompensation
5448000
us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
2000000
us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
10848000
eras Issuanceofcommonstocktoerascafoundations
Issuanceofcommonstocktoerascafoundations
17497000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
169000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-75000
eras Change In Fair Value Of Preferred Stock Purchase Right Liability
ChangeInFairValueOfPreferredStockPurchaseRightLiability
1615000
eras Increase Decrease In Prepaid Expenses And Other Current And Long Term Assets
IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAndLongTermAssets
4512000
eras Increase Decrease In Prepaid Expenses And Other Current And Long Term Assets
IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAndLongTermAssets
5592000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1540000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
409000
eras Increase Decrease In Accrued Expenses And Other Current Liabilities
IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities
2936000
eras Increase Decrease In Accrued Expenses And Other Current Liabilities
IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities
7173000
eras Increase Decrease In Operating Lease Assets And Liabilities Net
IncreaseDecreaseInOperatingLeaseAssetsAndLiabilitiesNet
-12431000
eras Increase Decrease In Operating Lease Assets And Liabilities Net
IncreaseDecreaseInOperatingLeaseAssetsAndLiabilitiesNet
-430000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-76892000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-57118000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
94427000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
41696000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
45900000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
54110000
us-gaap Payments To Acquire In Process Research And Development
PaymentsToAcquireInProcessResearchAndDevelopment
2000000
us-gaap Payments To Acquire In Process Research And Development
PaymentsToAcquireInProcessResearchAndDevelopment
7680000
us-gaap Payments To Acquire Equity Securities Fv Ni
PaymentsToAcquireEquitySecuritiesFvNi
2000000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
13687000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5375000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-66214000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-641000
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
316999000
us-gaap Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
119393000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1262000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1345000
eras Proceeds From Issuance Of Common Stock Under The Employee Stock Purchase Plan
ProceedsFromIssuanceOfCommonStockUnderTheEmployeeStockPurchasePlan
617000
eras Proceeds From The Disgorgement Of Stockholders Short Swing Profits
ProceedsFromTheDisgorgementOfStockholdersShortSwingProfits
553000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1879000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
438290000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-141227000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
380531000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
360895000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
65688000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
219668000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
446219000
eras Issuance Of Common Stock To Erasca Foundation
IssuanceOfCommonStockToErascaFoundation
-17497000
eras Issuance Of Common Stock In Connection With Asset Acquisition
IssuanceOfCommonStockInConnectionWithAssetAcquisition
1680000
eras Issuance Of Common Stock In Connection With License Agreement
IssuanceOfCommonStockInConnectionWithLicenseAgreement
5488000
eras Amounts Accrued For Purchase Of Property And Equipment
AmountsAccruedForPurchaseOfPropertyAndEquipment
841000
eras Amounts Accrued For Purchase Of Property And Equipment
AmountsAccruedForPurchaseOfPropertyAndEquipment
1882000
us-gaap Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
340798000
eras Vesting Of Early Exercised Options
VestingOfEarlyExercisedOptions
955000
eras Vesting Of Early Exercised Options
VestingOfEarlyExercisedOptions
519000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
22704000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
17498000
eras Reduction In Operating Lease Assets Due To Lease Amendment
ReductionInOperatingLeaseAssetsDueToLeaseAmendment
3361000
eras Tenant Improvement Allowance Included In Operating Lease Liabilities
TenantImprovementAllowanceIncludedInOperatingLeaseLiabilities
16774000
CY2022Q3 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
355900000
CY2022Q3 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
9600000
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-345700000
us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
On July 9, 2021, the Company effected a one-for-1.2 reverse stock split of its issued and outstanding shares of common stock (the Reverse Stock Split).
CY2021Q3 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
1.2
us-gaap Use Of Estimates
UseOfEstimates
<p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Use of estimates</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"/> </p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">The preparation of the Company’s condensed consolidated financial statements in conformity with US GAAP requires the Company to make estimates and assumptions that impact the reported amounts of assets, liabilities, expenses, and the disclosure of contingent assets and liabilities in the condensed consolidated financial statements and accompanying notes. Accounting estimates and management judgments reflected in the condensed consolidated financial statements include, but are not limited to, the accrual of research and development expenses, fair value of common stock, preferred stock and freestanding instruments, stock-based compensation expense, and the incremental borrowing rate for determining the operating lease asset and liability. Management evaluates its estimates on an ongoing basis. Although estimates are based on the Company’s historical experience, knowledge of current events, and actions it may undertake in the future, actual results may ultimately materially differ from these estimates and assumptions.</span></p>
CY2021Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
408000
CY2022Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
408000
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
219260000
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
445811000
CY2022Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
408000
CY2021Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
408000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
219668000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
446219000
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
0
CY2022Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
147616000
CY2022Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
7000
CY2022Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
1386000
CY2022Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
146237000
CY2021Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
98920000
CY2021Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
162000
CY2021Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
98758000
CY2022Q3 us-gaap Debt Securities Available For Sale Unrealized Loss Position Number Of Positions
DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
30
CY2022Q3 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
88000000.0
CY2022Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Number Of Positions
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
0
CY2021Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position Number Of Positions
DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
19
CY2021Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
68000000.0
CY2022Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
27442000
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
17681000
CY2022Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2567000
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1727000
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
24875000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
15954000
CY2022Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
771000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1700000
CY2021Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
191000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
509000
CY2022Q3 eras Accrued Research And Development Expenses Current
AccruedResearchAndDevelopmentExpensesCurrent
11623000
CY2021Q4 eras Accrued Research And Development Expenses Current
AccruedResearchAndDevelopmentExpensesCurrent
9122000
CY2022Q3 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
7104000
CY2021Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
7275000
CY2022Q3 eras Unvested Early Exercised Stock Option Liability
UnvestedEarlyExercisedStockOptionLiability
1929000
CY2021Q4 eras Unvested Early Exercised Stock Option Liability
UnvestedEarlyExercisedStockOptionLiability
2884000
CY2022Q3 eras Accrued Property And Equipment Current
AccruedPropertyAndEquipmentCurrent
273000
CY2021Q4 eras Accrued Property And Equipment Current
AccruedPropertyAndEquipmentCurrent
1272000
CY2022Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1048000
CY2021Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
383000
CY2022Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
355000
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
483000
CY2022Q3 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
22332000
CY2021Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
21419000
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
800000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
800000000
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
122306969
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
121382547
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
121024938
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
119102505
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Rights
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights
The restricted stock vests 25% one year from the vesting commencement date and monthly thereafter over a three-year period and is subject to repurchase by the Company in the event of any voluntary or involuntary termination of services to the Company prior to vesting.
CY2022Q3 eras Shares Of Common Stock Subject To Repurchase
SharesOfCommonStockSubjectToRepurchase
0
CY2021Q4 eras Shares Of Common Stock Subject To Repurchase
SharesOfCommonStockSubjectToRepurchase
212674
CY2022Q3 eras Share Based Compensation Arrangement By Share Based Payment Award Shares Subject To Repurchase
ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesSubjectToRepurchase
1282031
CY2021Q4 eras Share Based Compensation Arrangement By Share Based Payment Award Shares Subject To Repurchase
ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesSubjectToRepurchase
1854427
CY2021Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
905000
us-gaap Short Term Lease Cost
ShortTermLeaseCost
86000
CY2022Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5232000
CY2021Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3017000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
14729000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5448000
CY2022Q3 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
34830360
CY2021Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
29685655
eras Operating Leases Cancelable And Non Cancellable Expiration Dates
OperatingLeasesCancelableAndNonCancellableExpirationDates
2032
eras Operating Leases Non Cancelable Expiration Dates
OperatingLeasesNonCancelableExpirationDates
2026
CY2022Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
2600000
us-gaap Operating Lease Cost
OperatingLeaseCost
5100000
CY2022Q3 us-gaap Variable Lease Cost
VariableLeaseCost
701000
us-gaap Variable Lease Cost
VariableLeaseCost
1100000
CY2022Q3 us-gaap Short Term Lease Cost
ShortTermLeaseCost
24000
us-gaap Operating Lease Cost
OperatingLeaseCost
1600000
CY2021Q3 us-gaap Variable Lease Cost
VariableLeaseCost
96000
us-gaap Variable Lease Cost
VariableLeaseCost
324000
CY2021Q3 us-gaap Short Term Lease Cost
ShortTermLeaseCost
30000
us-gaap Short Term Lease Cost
ShortTermLeaseCost
89000
us-gaap Operating Lease Payments
OperatingLeasePayments
585000
us-gaap Operating Lease Payments
OperatingLeasePayments
803000
CY2022Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P9Y6M
CY2022Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0897
CY2021Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P9Y10M9D
CY2021Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.069
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
640000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
6858000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
8752000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
9024000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
9170000
CY2022Q3 eras Lessee Operating Lease Liability Payments Due After Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
53574000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
88018000
CY2022Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
31026000
CY2022Q3 eras Lessee Operating Lease Liability Tenant Improvement Allowance Receivable
LesseeOperatingLeaseLiabilityTenantImprovementAllowanceReceivable
2533000
CY2022Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
54459000
CY2022Q3 us-gaap Federal Income Tax Expense Benefit Continuing Operations
FederalIncomeTaxExpenseBenefitContinuingOperations
0
CY2021Q3 us-gaap Federal Income Tax Expense Benefit Continuing Operations
FederalIncomeTaxExpenseBenefitContinuingOperations
0
us-gaap Federal Income Tax Expense Benefit Continuing Operations
FederalIncomeTaxExpenseBenefitContinuingOperations
0
us-gaap Federal Income Tax Expense Benefit Continuing Operations
FederalIncomeTaxExpenseBenefitContinuingOperations
0
CY2022Q3 us-gaap State And Local Income Tax Expense Benefit Continuing Operations
StateAndLocalIncomeTaxExpenseBenefitContinuingOperations
0
us-gaap State And Local Income Tax Expense Benefit Continuing Operations
StateAndLocalIncomeTaxExpenseBenefitContinuingOperations
0
CY2022Q3 us-gaap Foreign Income Tax Expense Benefit Continuing Operations
ForeignIncomeTaxExpenseBenefitContinuingOperations
0
us-gaap Foreign Income Tax Expense Benefit Continuing Operations
ForeignIncomeTaxExpenseBenefitContinuingOperations
0
CY2021Q3 us-gaap State And Local Income Tax Expense Benefit Continuing Operations
StateAndLocalIncomeTaxExpenseBenefitContinuingOperations
0
us-gaap State And Local Income Tax Expense Benefit Continuing Operations
StateAndLocalIncomeTaxExpenseBenefitContinuingOperations
0
CY2021Q3 us-gaap Foreign Income Tax Expense Benefit Continuing Operations
ForeignIncomeTaxExpenseBenefitContinuingOperations
0
us-gaap Foreign Income Tax Expense Benefit Continuing Operations
ForeignIncomeTaxExpenseBenefitContinuingOperations
0
CY2022Q3 us-gaap Income Tax Examination Penalties And Interest Expense
IncomeTaxExaminationPenaltiesAndInterestExpense
0
CY2021Q3 us-gaap Income Tax Examination Penalties And Interest Expense
IncomeTaxExaminationPenaltiesAndInterestExpense
0
us-gaap Income Tax Examination Penalties And Interest Expense
IncomeTaxExaminationPenaltiesAndInterestExpense
0
us-gaap Income Tax Examination Penalties And Interest Expense
IncomeTaxExaminationPenaltiesAndInterestExpense
0
CY2022Q3 eras Employee Retention Credit Cares Act
EmployeeRetentionCreditCaresAct
2200000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-35489000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-46069000
us-gaap Net Income Loss
NetIncomeLoss
-107555000
us-gaap Net Income Loss
NetIncomeLoss
-92300000
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
120798322
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
120798322
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
99127286
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
99127286
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
120166023
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
120166023
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
48584029
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
48584029
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.29
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.29
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.46
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.46
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.90
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.90
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.90
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.90
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
19800563
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
16686041

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
0000950170-22-023926-index-headers.html Edgar Link pending
0000950170-22-023926-index.html Edgar Link pending
0000950170-22-023926.txt Edgar Link pending
0000950170-22-023926-xbrl.zip Edgar Link pending
eras-20220930.htm Edgar Link pending
eras-20220930.xsd Edgar Link pending
eras-ex31_1.htm Edgar Link pending
eras-ex31_2.htm Edgar Link pending
eras-ex32_1.htm Edgar Link pending
eras-ex32_2.htm Edgar Link pending
eras-20220930_cal.xml Edgar Link unprocessable
eras-20220930_def.xml Edgar Link unprocessable
eras-20220930_lab.xml Edgar Link unprocessable
eras-20220930_pre.xml Edgar Link unprocessable
eras-20220930_htm.xml Edgar Link completed
Financial_Report.xlsx Edgar Link pending
img197769362_0.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending